ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is immunohistochemically defined by the lack of expression of estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2).